IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN CENTRAL AMERICA

被引：0
|
作者：
Lopez-Cabra, C. [1 ]
Rodriguez, A. D. [2 ]
Mogollon, W. Mayorga [2 ]
Chavez, M. A. [3 ]
Patino, A. [1 ]
Herran, S. E. [4 ]
Marrugo, R. [4 ]
机构：
[1] Bayer, Bogota, CUN, Colombia
[2] Numeris, Bogota, Colombia
[3] Bayer, San Jose, Costa Rica
[4] Bayer, Bogota, Colombia
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE547
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [21] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis M.
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2020, 142 (24) : E470 - E470
  • [22] Real-World Effectiveness of Finerenone in Chinese Patients with Type 2 Diabetes Mellitus (T2MD) and Chronic Kidney Disease (CKD)
    Li, Ang
    Gao, Ying
    Guo, Xiaohui
    Zhang, Junqing
    DIABETES, 2024, 73
  • [23] Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Bakris, George L.
    Rossing, Peter
    Ruilope, Luis M.
    Coats, Andrew J. S.
    von Haehling, Stephan
    Ponikowski, Piotr
    Rosano, Giuseppe M. C.
    Brinker, Meike
    Farjat, Alfredo E.
    Roberts, Luke
    Pitt, Bertram
    ESC HEART FAILURE, 2025, 12 (01): : 185 - 188
  • [24] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2021, 143 (06) : 540 - 552
  • [25] FINERENONE ADDED TO TREATMENT GUIDELINES FOR TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2023, 123 (05) : 23 - 23
  • [26] Mediators of the Effects of Canagliflozin (CANA) on Heart Failure (HF) and CV Death in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)
    Li, Jingwei
    Neal, Bruce
    Heerspink, Hiddo L.
    Arnott, Clare
    Cannon, Christopher
    Agarwal, Rajiv
    Bakris, George
    Charytan, David M.
    de Zeeuw, Dick
    Greene, Tom
    Levin, Adeera
    Oh, Richard
    Pollock, Carol A.
    Wheeler, David C.
    Yavin, Yshai
    Zhang, Hong
    Zinman, Bernard
    Di Tanna, Gian Luca
    Perkovic, Vlado
    Mahaffey, Kenneth W.
    Jardine, Meg
    DIABETES, 2020, 69
  • [27] FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Pochopien, Michal T.
    Cherney, David Z., I
    Folkerts, Kerstin
    Levy, Pierre
    Millier, Aurelie
    Morris, Stephen
    Roy-Chaudhury, Prabir
    Sullivan, Sean D.
    Mernagh, Paul
    AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (20): : S375 - S382
  • [28] ECONOMIC BURDEN AMONG CHRONIC KIDNEY DISEASE (CKD) PATIENTS WITH AND WITHOUT TYPE 2 DIABETES (T2D) IN A COMMERCIALLY INSURED/MEDICARE ADVANTAGE (MA) POPULATION IN THE UNITED STATES (US)
    Chung, H.
    Thomas, N.
    Willey, V
    Kong, S. X.
    Singh, R.
    Farej, R.
    Williamson, T.
    VALUE IN HEALTH, 2022, 25 (07) : S381 - S381
  • [29] Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease
    Filippatos, Gerasimos
    Anker, Stefan D.
    Pitt, Bertram
    McGuire, Darren K.
    Rossing, Peter
    Ruilope, Luis M.
    Butler, Javed
    Jankowska, Ewa A.
    Michos, Erin D.
    Farmakis, Dimitrios
    Farjat, Alfredo E.
    Kolkhof, Peter
    Scalise, Andrea
    Joseph, Amer
    Bakris, George L.
    Agarwal, Rajiv
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 9 (01) : 85 - 93
  • [30] Distance to Glycemic Target of Patients (Pts) with Type 2 Diabetes (T2D) and Established Cardiovascular Disease (eCVD) and/or Chronic Kidney Disease (CKD) Failing Metformin Monotherapy in the US
    Fernandes, Gail
    Sawhney, Baanie
    Hannachi, Hakima
    Wang, Tongtong
    Mcneill, Ann Marie
    DIABETES, 2019, 68
12345